Published Date: 17 Mar 2023
The American College of Rheumatology (ACR) and the American College of Hip Surgery (AAHKS) have released new guidelines.
Read Full NewsBritish lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...
In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.
Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.
Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.
In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.
For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.
1.
Atezolizumab + Cabozantinib Postpones mCRPC Progression.
2.
Survivors of childhood brain cancer are more likely to be held back in school
3.
Abnormal Shadow on Chest Radiograph
4.
Hit and Miss for CDK4/6 Inhibitor in Recurrent Brain Cancer
5.
Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.
1.
Benefits of Neutrophilia: Harnessing the Power of White Blood Cells to Promote Health and Well-Being
2.
Oncology Drug Handling Near-Misses: Clinical Risks, Pathophysiology, and Guideline-Based Approaches
3.
Cardio-Oncology: Managing Heart Failure in Survivors of Cancer
4.
Rehabilitation Through Prehabilitation Before Complex Cancer Surgery
5.
Breaking Down Leukocytoclastic Vasculitis: Causes, Symptoms and Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Blood Clotting Disorders Explained
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation